Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | XDH | P47989 | 5/20 | 0.48 |
| ▸ | PNP | P00491 | 5/20 | 0.47 |
| ▸ | TK1 | P04183 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | VCP | P55072 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22704545 | 0.90 | MEN1 (0.49) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL18769787 | 0.89 | MEN1 (0.51) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL21090694 | 0.87 | MEN1 (0.47) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL22021887 | 0.84 | MEN1 (0.51) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL5021598 | 0.83 | XDH (0.55) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL25077455 | 0.83 | PNP (0.50) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL21417341 | 0.82 | XDH (0.53) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL25768230 | 0.82 | PNP (0.49) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL25976707 | 0.81 | PNP (0.48) | MEN1KMT2AXDHPNPTK1 | |
| SCHEMBL24767723 | 0.80 | PNP (0.47) | MEN1KMT2APNPALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200231620-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200231620-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | MEN1 3382/4885KMT2A 1707/4885XDH 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.